 Crinetics Pharmaceuticals Inc NASDAQ:CRNX major shareholder Vivo Capital Viii, Llc sold 84,598 shares of the stock in a transaction dated Friday, April 17th. The stock was sold at an average price of 15.40, for a total value of 1,302,809.20. The transaction was disclosed in a legal filing with the SEC, which is available at this ... 